Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Glenn Buttermann

Orthopaedic Surgery of the Spine Roseville, MN Medical Doctor

NPI 1598712788 CMS profile 207610

1835 County Road C W Ste 150, Ste 102, Roseville, MN 55113

Open in the dashboard

General payments

$258,593

121 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$8,553 paid to institutions, not to them · program years 2019–2021

Through program year 2025, Glenn Buttermann of Roseville, MN is reported in the CMS Open Payments database as having received $258,593 across 121 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $8,553 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 86th percentile of Orthopaedic Surgery of the Spine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $870 14
2024 General $1,174 11
2023 General $1,457 7
2022 General $35,307 17
2021 General $42,244 8
2020 General $84,228 22
2019 General $93,313 42

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Glenn Buttermann
  • Orthopaedic Surgery of the Spine median
  • Middle half of Orthopaedic Surgery of the Spine
  • National median

In program year 2025, general payments to Glenn Buttermann were reported at $870. Among 1,704 Orthopaedic Surgery of the Spine profiles paid that year, the median was $2,061 and the middle half received between $347 and $14,651.

Show as a table
Year Glenn Buttermann Orthopaedic Surgery of the Spine median Middle half National median
2019 $93,313 $2,106 $337–$18,608 $163
2020 $84,228 $1,213 $156–$15,082 $114
2021 $42,244 $1,834 $271–$15,617 $132
2022 $35,307 $2,015 $320–$17,036 $149
2023 $1,457 $1,925 $336–$14,599 $160
2024 $1,174 $2,110 $341–$12,483 $164
2025 $870 $2,061 $347–$14,651 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. First Gold Corp $235,700 5 payments
  2. Aesculap Implant Systems, LLC $7,673 15 payments
  3. Orthofix Medical, Inc. $7,603 15 payments
  4. Globus Medical, Inc. $1,661 14 payments
  5. Spineart USA Inc $1,208 10 payments
  6. Seaspine Orthopedics Corporation $918 7 payments
  7. Stryker Corporation $785 7 payments
  8. Nexxt Spine LLC $700 1 payment
  9. ulrich medical USA, Inc. $339 5 payments
  10. Cerapedics, Inc. $297 6 payments
  11. Other $1,709 36 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $248,813 13 payments
  2. Travel and Lodging $5,210 22 payments
  3. Food and Beverage $4,549 85 payments
  4. Gift $22 1 payment
Products named General payments · program years 2019–2025
  1. ACTIVL ARTIFICIAL DISC $7,673 15 payments
  2. 4CIS AUGUSTA PEEK ALIF CAGE $1,200 1 payment
  3. M6-C $1,120 7 payments
  4. Excelsius - GPS $725 7 payments
  5. CREO Self Drilling Screw $713 2 payments
  6. Facet Fixx $700 1 payment
  7. M6-C Artificial Cervical Disc $522 4 payments
  8. NEW PRODUCT DEVELOPMENT $330 1 payment
  9. I-FACTOR PEPTIDE ENHANCED BONE GRAFT $297 6 payments
  10. TRITANIUM $201 2 payments
  11. Other $2,233 48 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 4 drugs

Part D claims

58

Median for Orthopedic Surgery: 203

Drug cost

$28,724

Median for Orthopedic Surgery: $1,433

Branded share of claims

41.4%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Tymlos Abaloparatide Brand 11 $28,283
Gabapentin Generic 22 $274
Vitamin D2 Ergocalciferol (Vitamin D2) Brand 13 $88
Methylprednisolone Generic 12 $78

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 47 billing codes

Paid by Medicare

$64,750

Medicare's payments for the services billed

Medicare patients

56

Average age 65

Services billed

284

38 women, 18 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 70%
Osteoporosis 50%
Depression 46%
Diabetes 23%
COPD 23%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

121 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery of the Spine in Minnesota

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record